Anders Mattson

Title: The Innovative Contributions of Anders Mattson

Introduction

Anders Mattson is a notable inventor based in Södertälje, Sweden. He has made significant contributions to the field of pharmaceuticals, particularly in the development of novel compounds. With a total of 9 patents to his name, his work has had a considerable impact on medical science.

Latest Patents

One of his latest patents involves a novel form of the (−)-enantiomer of 5-methoxy-2-[[(4-methoxy-3,5-dimethyl-2-pyridinyl)-methyl]sulfinyl]-1-benzimidazole, known as S-omeprazole. This invention specifically relates to a new form of the magnesium salt of the S-enantiomer of omeprazole trihydrate. Additionally, it encompasses processes for preparing this magnesium salt form and pharmaceutical compositions that contain it. The invention also introduces new intermediates used in the preparation process.

Career Highlights

Anders Mattson is currently employed at AstraZeneca AB, a leading global biopharmaceutical company. His work at AstraZeneca has allowed him to focus on innovative drug development, contributing to advancements in therapeutic options for various medical conditions.

Collaborations

Throughout his career, Anders has collaborated with several talented individuals, including Hanna Cotton and Anders Kronström. These collaborations have fostered a creative environment that has led to the successful development of new pharmaceutical solutions.

Conclusion

Anders Mattson's contributions to the field of pharmaceuticals through his innovative patents and collaborations highlight his importance as an inventor. His work continues to influence the development of effective medical treatments.